A Phase 3 Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell Lymphoma.
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 15 Nov 2013
At a glance
- Drugs Cyclophosphamide; Denileukin diftitox; Doxorubicin; Prednisone; Vincristine
- Indications Peripheral T-cell lymphoma
- Focus Registrational; Therapeutic Use
- 15 Nov 2013 Planned end date changed from 1 Jan 2015 to 1 Nov 2014 as reported by ClinicalTrials.gov.
- 16 Sep 2011 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 23 May 2011 New trial record